⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43847 | 0.93 | — | — | |
| SCHEMBL100142 | 0.91 | — | — | |
| SCHEMBL2942594 | 0.88 | ALDH1A1 (0.39) | — | |
| SCHEMBL5984718 | 0.88 | ALDH1A1 (0.39) | — | |
| SCHEMBL5136351 | 0.88 | — | — | |
| SCHEMBL82508 | 0.87 | — | — | |
| SCHEMBL5819760 | 0.86 | TRPM8 (0.30) | — | |
| SCHEMBL102730 | 0.86 | ALDH1A1 (0.54) | — | |
| SCHEMBL27370708 | 0.86 | — | — | |
| SCHEMBL5985180 | 0.84 | ALDH1A1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118201905-A | Cationic lipid | 武田药品工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-116867828-A | Curable composition | 住友化学株式会社 | 2023-10-10 | — | — | CN | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| WO-2022172781-A1 | CURABLE COMPOSITION | 住友化学株式会社 | 2022-08-18 | — | — | WO | disclosed |
| EP-3098273-B1 | DISPERSION CONTAINING METAL OXIDE PARTICLES | NIPPON CATALYTIC CHEM IND (JP) | 2022-07-06 | — | — | EP | disclosed |
| US-20220064372-A1 | POLYCARBONATE POLYOL AND USES OF THE SAME | DAIREN CHEMICAL CORPORATION (TW) | 2022-03-03 | — | — | US | disclosed |
| CN-114106314-A | Polycarbonate polyols and use thereof | 大连化学工业股份有限公司 | 2022-03-01 | — | — | CN | disclosed |
| EP-3290426-B1 | 2-CYANOETHYL-CONTAINING ORGANOXYSILANE COMPOUND, SILSESQUIOXANE, AND MAKING METHODS | SHINETSU CHEMICAL CO (JP) | 2021-11-17 | — | — | EP | disclosed |
| CN-105934485-B | Dispersion containing metal oxide particle | 株式会社日本触媒 | 2019-04-09 | — | — | CN | disclosed |
| US-10066087-B2 | Dispersion containing metal oxide particles | NIPPON SHOKUBAI CO., LTD. (JP) | 2018-09-04 | — | — | US | disclosed |
| EP-1300405-A1 | AMINO ALCOHOL DERIVATIVES | Sankyo Company, Limited (JP) | 2003-04-09 | — | — | EP | disclosed |
| EP-1219631-A1 | ANTIANDROGEN AGENTS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-07-03 | — | — | EP | disclosed |
| US-6410523-B1 | BONE DEFECTS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-06-25 | — | — | US | disclosed |
| US-20020045772-A1 | Vitamin D derivative having substituent at 2beta-position | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-04-18 | — | — | US | disclosed |
| EP-1070704-A1 | VITAMIN D DERIVATIVES SUBSTITUTED AT THE 2$g(b)-POSITION | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2001-01-24 | — | — | EP | disclosed |
| EP-0632036-B1 | Amide derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO CO (JP) | 2000-03-01 | — | — | EP | disclosed |
| US-5614550-A | ANTICHOLESTEROL AGENTS OR ARTERIOSCLEROSIS AGENTS FOR HUMANS | SANKYO COMPANY, LIMITED (JP) | 1997-03-25 | — | — | US | disclosed |
| US-5534529-A | Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY, LIMITED (JP) | 1996-07-09 | — | — | US | disclosed |
| CN-1105984-A | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO CO (JP) | 1995-08-02 | — | — | CN | disclosed |
| EP-0632036-A2 | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY LIMITED (JP) | 1995-01-04 | — | — | EP | disclosed |